A top trade group for pharmaceutical companies has asked the US supreme court not to shred the power of the Food and Drug Administration (FDA) in an upcoming case that could cut access to a drug commonly used in abortions. But in a move that appears to undermine its own position, it has also given more than $125,000 to a GOP organization that backs the Republicans who want the supreme court to do exactly the opposite.
The trade group, Pharmaceutical Research and Manufacturers of America, or PhRMA, lobbies on behalf of brand-name drug manufacturers. In October and January, it filed briefs in an upcoming supreme court case that threatens to curtail access to a common abortion drug called mifepristone.
